Angcon, Noveln .

HRN: 22-47-10  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
01/09/2023
CEFUROXIME 750MG (VIAL)
01/09/2023
01/16/2023
IV
750mg
Q8H
UTI

 Indication:  Prophylaxis    Type of Infection:  Reproductive Tract    Compliance to guidelines: Non-compliant To Guidelines